Terms: = Germ cell tumor AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
170 results:
1. 68 Ga-Pentixafor PET/CT for In Vivo Imaging of cxcr4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.
Waheed A; Singh B; Watts A; Kaur H; Singh H; Dhingra K; Ahuja C; Madan R; Singh A; Radotra BD
Clin Nucl Med; 2024 Apr; 49(4):e141-e148. PubMed ID: 38350065
[TBL] [Abstract] [Full Text] [Related]
2. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors.
Lai TY; Chiang TC; Lee CY; Kuo TC; Wu CH; Chen YI; Hu CM; Maskey M; Tang SC; Jeng YM; Tien YW; Lee EYP; Lee WH
Br J Cancer; 2024 Apr; 130(7):1096-1108. PubMed ID: 38341509
[TBL] [Abstract] [Full Text] [Related]
3. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
4. Bone Marrow Stromal cells inhibited the growth and metastasis of human U87 cells through delivering exosomal miR-506.
Zhang L; Ding Y; Zhou W; Xu X; Zheng J
Medicine (Baltimore); 2023 Dec; 102(49):e36582. PubMed ID: 38065867
[TBL] [Abstract] [Full Text] [Related]
5. Chemokine receptor cxcr4 interacts with nuclear receptor Nur77 and promote glioma invasion and progression.
Dai Y; Yu C; Zhou L; Cheng L; Ni H; Liang W
Brain Res; 2024 Jan; 1822():148647. PubMed ID: 37890573
[TBL] [Abstract] [Full Text] [Related]
6. Mavorixafor, an Orally Bioavailable cxcr4 Antagonist, Increases Immune cell Infiltration and Inflammatory Status of tumor Microenvironment in Patients with Melanoma.
Andtbacka RHI; Wang Y; Pierce RH; Campbell JS; Yushak M; Milhem M; Ross M; Niland K; Arbeit RD; Parasuraman S; Bickley K; Yeung CC; Aicher LD; Smythe KS; Gan L
Cancer Res Commun; 2022 Aug; 2(8):904-913. PubMed ID: 36923305
[TBL] [Abstract] [Full Text] [Related]
7. Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes.
Chen J; Kang Z; Li S; Wang C; Zheng X; Cai Z; Pan L; Chen F; Li W
Front Immunol; 2022; 13():911260. PubMed ID: 35967388
[TBL] [Abstract] [Full Text] [Related]
8. MYCN and HIF-1 directly regulate
Hains AE; Uppal S; Cao JZ; Salwen HR; Applebaum MA; Cohn SL; Godley LA
Epigenetics; 2022 Dec; 17(13):2056-2074. PubMed ID: 35942521
[TBL] [Abstract] [Full Text] [Related]
9. Identification and characterization of sex-dependent gene expression profile in glioblastoma.
Qin S; Yuan Y; Liu H; Pu Y; Chen K; Wu Y; Su Z
Neuropathology; 2023 Feb; 43(1):72-83. PubMed ID: 35789505
[TBL] [Abstract] [Full Text] [Related]
10. The involvement of a chemokine receptor antagonist CTCE-9908 and kynurenine metabolites in cancer development.
Nkandeu DS; Basson C; Joubert AM; Serem JC; Bipath P; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2022 Aug; 40(6):608-622. PubMed ID: 35789495
[TBL] [Abstract] [Full Text] [Related]
11. Preclinical platforms to study therapeutic efficacy of human γδ T cells.
Ou L; Wang H; Huang H; Zhou Z; Lin Q; Guo Y; Mitchell T; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Guo W; Salvino J; Herlyn M; Xu X
Clin Transl Med; 2022 Jun; 12(6):e814. PubMed ID: 35731974
[TBL] [Abstract] [Full Text] [Related]
12. Glioblastoma-associated microglia-derived exosomal circKIF18A promotes angiogenesis by targeting FOXC2.
Jiang Y; Zhao J; Xu J; Zhang H; Zhou J; Li H; Zhang G; Xu K; Jing Z
Oncogene; 2022 Jun; 41(26):3461-3473. PubMed ID: 35637250
[TBL] [Abstract] [Full Text] [Related]
13. Systemic Delivery of an Adjuvant cxcr4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.
Alghamri MS; Banerjee K; Mujeeb AA; Mauser A; Taher A; Thalla R; McClellan BL; Varela ML; Stamatovic SM; Martinez-Revollar G; Andjelkovic AV; Gregory JV; Kadiyala P; Calinescu A; Jiménez JA; Apfelbaum AA; Lawlor ER; Carney S; Comba A; Faisal SM; Barissi M; Edwards MB; Appelman H; Sun Y; Gan J; Ackermann R; Schwendeman A; Candolfi M; Olin MR; Lahann J; Lowenstein PR; Castro MG
ACS Nano; 2022 Jun; 16(6):8729-8750. PubMed ID: 35616289
[TBL] [Abstract] [Full Text] [Related]
14. Regorafenib Reverses Temozolomide-Induced CXCL12/cxcr4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma.
Chiang IT; Liu YC; Liu HS; Ali AAA; Chou SY; Hsu TI; Hsu FT
Neurotherapeutics; 2022 Mar; 19(2):616-634. PubMed ID: 35267171
[TBL] [Abstract] [Full Text] [Related]
15. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract] [Full Text] [Related]
16. C-X-C Chemokine Receptor Type 4-Targeted Imaging in Glioblastoma Multiforme Using
Zhang X; Detering L; Sultan D; Heo GS; Luehmann H; Taylor S; Choksi A; Rubin JB; Liu Y
ACS Appl Bio Mater; 2022 Jan; 5(1):235-242. PubMed ID: 35014818
[TBL] [Abstract] [Full Text] [Related]
17. The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma cell Migration via the SDF1/cxcr4 Pathway.
Sánchez-Sánchez AV; García-España A; Sánchez-Gómez P; Font-de-Mora J; Merino M; Mullor JL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638956
[TBL] [Abstract] [Full Text] [Related]
18. Current Challenges in Targeting tumor Desmoplasia to Improve the Efficacy of Immunotherapy.
Kasperska A; Borowczak J; Szczerbowski K; Stec E; Ahmadi N; Szylber Ł
Curr Cancer Drug Targets; 2021; 21(11):919-931. PubMed ID: 34525931
[TBL] [Abstract] [Full Text] [Related]
19. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/cxcr4 axis by regulating autophagy in gastric cancer.
Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
[TBL] [Abstract] [Full Text] [Related]
20. Melanoma-derived extracellular vesicles skew neutrophils into a pro-tumor phenotype.
Guimarães-Bastos D; Frony AC; Barja-Fidalgo C; Moraes JA
J Leukoc Biol; 2022 Mar; 111(3):585-596. PubMed ID: 34043843
[TBL] [Abstract] [Full Text] [Related]
[Next]
